October 22, 2020
Podcast
Dr. Schaffner explains how social distancing and masks could also reduce the spread of influenza.
October 02, 2020
What the potential of monoclonal antibodies may be, and what's currently understood about serologic antibodies.
September 24, 2020
Article
The trial was called off because of futility of the toxoid vaccine candidate.
August 26, 2020
Approximately 11.7% of nearly 90,000 hospitalized patients with confirmed influenza suffered from an acute cardiovascular event.
August 07, 2020
A famed virologist weighs in on the country's earliest shortcomings—and how they can still be resolved today.
July 20, 2020
The vaccine induced T cell response in about 2 weeks, and antibody response in about 4 weeks, among 1000-plus healthy adults.
May 10, 2020
Why the virus is burdening US populations similar to other diseases.
February 12, 2020
Older patients with no stroke history are shown to have reduced risk for both shingles and stroke in new CDC data.
February 03, 2020
Seqirus announced approval of influenza A monovalent vaccine, adjuvanted (Audenz™) for protection against influenza A in a release on Monday morning.
January 23, 2020
New data for the 2019-2020 season shows the virus is at a high activity, but disease severity is moderate.
